- Home
- AMLX vs LEO Comparison
AMLX vs LEO Comparison
Compare AMLX & LEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- LEO
- Stock Information
- Founded
- AMLX 2014
- LEO 1987
- Country
- AMLX United States
- LEO United States
- Employees
- AMLX N/A
- LEO N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- LEO Trusts Except Educational Religious and Charitable
- Sector
- AMLX Health Care
- LEO Finance
- Exchange
- AMLX Nasdaq
- LEO Nasdaq
- Market Cap
- AMLX 481.9M
- LEO 394.9M
- IPO Year
- AMLX 2022
- LEO N/A
- Fundamental
- Price
- AMLX $4.76
- LEO $6.25
- Analyst Decision
- AMLX Buy
- LEO
- Analyst Count
- AMLX 7
- LEO 0
- Target Price
- AMLX $6.00
- LEO N/A
- AVG Volume (30 Days)
- AMLX 1.7M
- LEO 200.2K
- Earning Date
- AMLX 11-07-2024
- LEO 01-01-0001
- Dividend Yield
- AMLX N/A
- LEO 4.01%
- EPS Growth
- AMLX N/A
- LEO N/A
- EPS
- AMLX N/A
- LEO 0.04
- Revenue
- AMLX $196,485,000.00
- LEO N/A
- Revenue This Year
- AMLX N/A
- LEO N/A
- Revenue Next Year
- AMLX $149.49
- LEO N/A
- P/E Ratio
- AMLX N/A
- LEO $152.00
- Revenue Growth
- AMLX N/A
- LEO N/A
- 52 Week Low
- AMLX $1.58
- LEO $4.98
- 52 Week High
- AMLX $19.95
- LEO $6.50
- Technical
- Relative Strength Index (RSI)
- AMLX 45.23
- LEO 44.12
- Support Level
- AMLX $4.88
- LEO $6.11
- Resistance Level
- AMLX $7.27
- LEO $6.36
- Average True Range (ATR)
- AMLX 0.59
- LEO 0.08
- MACD
- AMLX -0.18
- LEO 0.01
- Stochastic Oscillator
- AMLX 7.03
- LEO 61.54
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.
About LEO BNY Mellon Strategic Municipals Inc.
BNY Mellon Strategic Municipals, Inc. is a diversified closed-end management investment company. The fund's investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. Its products are Equity and Fixed Income Mutual Funds, Retail Money Market Funds, Government/Treasury Money Market Funds, Institutional Money Market Funds, and others.